Cancer cures are maddeningly elusive, but important victories have been achieved and others are on the horizon. Join us on the 10th anniversary of the...
5th Annual Gibco 24 Hours of Stem Cells (if you log on anytime after 8:00 a.m., regardless of your time zone, programming will have started or be in progress)
Harvard Medical School, New Research Building, Room 350, 77 Avenue Louis Pasteur, Boston, MA
Celixir plc is a UK stem cell company with two Phase 3 products, and is expected to IPO in 2018 with the founders still retaining 75% of the equity (after 5 rounds of external funding).
Founders Prof. Sir Martin Evans (2007 Nobel Laureate) and CEO Ajan Reginald (Former Global Head of New Technologies, Roche Pharmaceuticals),...
Celixir plc is a UK stem cell company with two Phase 3 products, and is expected to IPO in 2018 with the founders still retaining 75% of the equity (after 5 rounds of external funding).
Founders Prof. Sir Martin Evans (2007 Nobel Laureate) and CEO Ajan Reginald (Former Global Head of New Technologies, Roche...
Harvard Medical School, New Research Building, Room 1031, 77 Avenue Louis Pasteur, Boston, MA
Nanocourse of the Genetics Department
Lecturers: Ali Rudolph, Kelsey Tyssowski, Katherine Wu
In the era of fake news and alternative facts, communicating science clearly and effectively to the general public is more important than ever. From tweets to Facebook posts to news articles, there are countless media through which we can bring science to people from all walks of life. This nanocourse offers the opportunity to learn the basics of science writing for general audiences through...
Harvard Medical School, Armenise Amphitheater, 210 Longwood Avenue, Boston, MA
Nanocourse of the Genetics Department
Lecturers: J. Keith Joung, John Doench, and Morgan Maeder
Clustered regularly interspaced short palindromic repeat (CRISPR) RNAs and their CRISPR-associated (Cas) proteins are an important part of adaptive immune systems in many prokaryotes. CRISPR-Cas systems function as RNA-directed endonucleases that can target nucleic acids in a sequence-specific manner and are now widely used as genome editing tools. In this course, we will provide lectures...
Dana-Farber Cancer Institute, 450 Brookline Avenue, 3rd Floor, Boston, MA 02215
Please save the date (November 6th, 2017) for an upcoming half-day symposium to highlight the talent of junior investigators at Dana Farber/Harvard Cancer Center (DF/HCC) who are producing important research in several areas of population science, including epidemiology, biostatistics, outcomes, diversity and survivorship. A primary aim of this symposium is to build opportunities for collaboration for junior investigators and provide a forum for new interactions and projects...
The 8th International Wyss Symposium will focus on innovations in Therapeutic Organ Engineering, with the goal of sharing recent advances in 3D organ engineering,...
